The Company is also in early stage discussions to sell its product on TV
LOS ANGELES, July 12, 2018 (GLOBE NEWSWIRE) -- ViaDerma, Inc., (“Company”) (OTC Pink:VDRM), is pleased to announce it has posted a letter from President and CEO, Dr. Christopher Otiko on the Company’s website, www.viadermalicensing.com. (Link to CEO Letter)
- Registration of Vitastem with the National Agency for Food and Drug Administration and Control (NAFDAC), Nigeria’s equivalent to the FDA is in the final stages and expected to be completed very soon. At that time, Vage Nigeria Ltd. will pay a 50% deposit to ViaDerma in the amount of $125,000 for its initial order worth $250,000.
- Discussions with a South American distributor are ongoing and expected to result in a purchase of 200,000 units of Vitastem per month.
- The Company is realizing significant month to month increases in Vitastem sales on Amazon.
- Registering of Vitastem for medical insurance coverage is underway and expected to have final approval for insurance payments and reimbursements for January 2019.
© 2018 GlobeNewswire, Inc. All Rights Reserved.